Massachusetts
Healey lashes out at biotech firm over ‘unfair’ drug prices
BOSTON – Massachusetts Attorney General Maura Healey may go after Gilead Sciences over the price of its new hepatitis C treatment, Sovaldi, calling the $84,000 cost of a full treatment against the deadly disease potentially an illegal unfair trade practice. Healey referred to pricing for the drug as well as
